wexford labs
Home                About Us                 Products                Support & Training                MSDS & TDS                Contact Us
Disinfecting and Cleaning Solutions
Shelf Life
Green Cleaning
Service Disabled Veteran Partnership
Hand Hygiene
GSA/BPA Contracts
Skilcraft
Middle East Distribution
Resources

Ebola Virus Disease (EVD)

CDC Interim Guidance for Environmental Infection Control in Hospitals for Ebola Virus
August 1, 2014
Full CDC article

Relevant text regarding use of surface disinfectants:

Use a U.S. Environmental Protection Agency (EPA)‐registered hospital disinfectant with a label claim for a non‐enveloped virus (e.g., norovirus, rotavirus, adenovirus, poliovirus) to disinfect environmental surfaces in rooms of patients with suspected or confirmed Ebola virus infection. Although there are no products with specific label claims against the Ebola virus, enveloped viruses such as Ebola are susceptible to a broad range of hospital disinfectants used to disinfect hard, non‐porous surfaces. In contrast, non‐enveloped viruses are more resistant to disinfectants. As a precaution, selection of a disinfectant product with a higher potency than what is normally required for an enveloped virus is being recommended at this time. EPA‐registered hospital disinfectants with label claims against nonenveloped viruses (e.g., norovirus, rotavirus, adenovirus, and poliovirus) are broadly antiviral and capable of inactivating both enveloped and non‐enveloped viruses.

The following Wexford disinfectants meet the above criteria for use against Ebola:

  • Wex-Cide 128
  • Ready To Use Wex-Cide
  • Ready To Use Thymo-Cide
  • CleanCide Ready To Use
  • CleanCide Wipes
  • Wexford Disinfecting Wipes
  • Pro-Q 64
  • Pro-Q 128
  • Pro-Q 256
  • WP-01 (Wex-Cide 128)
  • WP-08 (Pro-Q 64)
  • WP-10 (Pro-Q 256)
© Wexford Labs 2010    325 Leffingwell Ave. Kirkwood, MO 63122

 

wexford-labs